Literature DB >> 973127

Neurophysiological findings among workers occupationally exposed to styrene.

A M Seppäläinen, H Härkönen.   

Abstract

Ninety-six male workers occupationally exposured to styrene in 24 plants producing reinforced polyester plastic products were studied neurophysiologically. The mean age of the subjects was 29.6 +/- 7.4 years, and the duration of the exposure varied from 6 months to 14 years (mean 5.0 years). Mandelic acid concentration in the urine (mean of five values determined during five consecutive weeks) was used as the measure of exposure. The individual means of the mandelic acid concentrations varied from 7 to 4,715 mg/dm3 (median 808 mg/dm3). Neurotoxic effects of styrene exposure upon the central nervous system were revealed by abnormalities in the EEG. The overall prevalence of abnormal EEGs was 24% (23 out of 96), which is higher than that found among a normal population (p less than 0.05). Abnormal EEGs were found in one-third of the subjects with relevant styrene exposure (mandelic acid concentration over 700 mg/dm3), while low-level styrene exposure did not increase the prevalence of normal EEGs above that found in a normal population. Nerve conduction velocity measurements performed on 40 subjects did not reveal any definite relationship between neuropathy and styrene exposure. The EEG examination is useful in the investigation of the neurotoxic effects of styrene. Whenever a possibility exists of excessive styrene exposure or beginning poisoning, the workers should be submitted to an EEG examination.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 973127     DOI: 10.5271/sjweh.2810

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  17 in total

1.  Otoneurological study in workers exposed to styrene in the fiberglass industry.

Authors:  G Calabrese; A Martini; G Sessa; M Cellini; G B Bartolucci; G Marcuzzo; E De Rosa
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

2.  Somatosensory evoked potentials in workers exposed to toluene and styrene.

Authors:  I Stĕtkárová; P Urban; B Procházka; E Lukás
Journal:  Br J Ind Med       Date:  1993-06

3.  [Biochemical examinations and measurements of conduction velocity of trichloroethylene exposed persons (author's transl)].

Authors:  G Triebig; T Reichenbach; K A Flügel
Journal:  Int Arch Occup Environ Health       Date:  1978-09-15       Impact factor: 3.015

4.  Relationship of symptoms to occupational styrene exposure and to the findings of electroencephalographic and psychological examinations.

Authors:  H Härkönen
Journal:  Int Arch Occup Environ Health       Date:  1977-12-22       Impact factor: 3.015

5.  Neurotoxic effects of styrene: further evidence.

Authors:  N Cherry; D Gautrin
Journal:  Br J Ind Med       Date:  1990-01

6.  Investigations on neurotoxicity of chemical substances at the workplace. VII. Longitudinal study with determination of nerve conduction velocities in persons occupationally exposed to styrene.

Authors:  G Triebig; K H Schaller; H Valentin
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

7.  Long term neurotoxicity of styrene. A quantitative study of glial fibrillary acidic protein (GFA) and S-100.

Authors:  L E Rosengren; K G Haglid
Journal:  Br J Ind Med       Date:  1989-05

8.  Neurologic dysfunction from exposure to 2-t-butylazo-2-hydroxy-5-methylhexane (BHMH): a new occupational neuropathy.

Authors:  J M Horan; T L Kurt; P J Landrigan; J M Melius; M Singal
Journal:  Am J Public Health       Date:  1985-05       Impact factor: 9.308

9.  Effects of chronic styrene inhalation on rat brain protein metabolism.

Authors:  H Savolainen; P Pfäffli
Journal:  Acta Neuropathol       Date:  1977-11-28       Impact factor: 17.088

10.  Peripheral markers of neurochemical function among workers exposed to styrene.

Authors:  H Checkoway; L G Costa; J Camp; T Coccini; W E Daniell; R L Dills
Journal:  Br J Ind Med       Date:  1992-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.